Traditionally, malignant biliary obstruction is relieved by placing a transpapillary stent during endoscopic retrograde cholangioscopy (ERCP). Pancreatitis is a possible adverse event of ERCP. Additionally,
EUS
EUS
Is Upfront EUS-Guided Biliary Drainage a Wise Option in Patients With Malignant Distal Biliary Obstruction?
Relief of Gastric Outlet Obstruction: Is Endoscopy Treatment Better Than Surgery?
Malignant gastric outlet obstruction (mGOO) results in significant morbidity and decreased quality of life. Treatment options include surgical gastrojejunostomy (SGJ) and endoscopic ultrasound-guided gastroenterostomy (EUS-GE).
EUS-RFA Is Highly Effective in the Treatment of Sporadic Pancreatic Insulinomas With Fewer Adverse Events Compared to Surgery
Sporadic pancreatic insulinomas (PIs) are challenging lesions with low oncologic risk but a high symptom burden. Despite their low malignant risk, the debilitating symptoms of
Does EUS-Guided Gastroenterostomy Improve Quality of Life in Patients With Malignant Gastric Outlet Obstruction?
Malignant gastric outlet obstruction (GOO) has a profound negative impact on quality of life (QoL). Options for palliation include surgical gastroenterostomy, enteral stent placement, and,
How Good Is Single-Incision Needle-Knife Biopsy in Diagnosing Gastrointestinal Subepithelial Tumors?
Tissue sampling of subepithelial lesions (SELs) is needed to determine the diagnosis, malignant potential, and management of these lesions. Endoscopic ultrasound-guided fine needle aspiration and/or
Is EUS-guided Ablation Feasible To Treat Nonfunctioning Pancreatic Neuroendocrine Tumors Smaller Than 2 cm?
Although small (<2 cm), nonfunctioning pancreatic neuroendocrine tumors (PNETs) are typically followed, there are instances, such as patient anxiety, that prompt resection. Endoscopic ultrasound-guided ethanol
Prevention of Cholecystitis in Patients Undergoing ERCP for Malignant Distal Biliary Obstruction Involving the Cystic Duct: A Novel Technique
Cholecystitis following biliary drainage with a self-expandable metallic stent (SEMS) in patients with distal malignant biliary obstruction (MBO) and cystic duct orifice involvement is significant.
Pancreatic Cancer Screening: Who Should We Consider?
The incidence of pancreatic cancer continues to grow, and despite advances in oncologic treatment, the mortality rate continues to be high. The goal of screening
